First Time Loading...

Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 161.36 USD -3.52%
Updated: Apr 25, 2024

Intrinsic Value

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. [ Read More ]

The intrinsic value of one PODD stock under the Base Case scenario is 84.86 USD. Compared to the current market price of 161.36 USD, Insulet Corp is Overvalued by 47%.

Key Points:
PODD Intrinsic Value
Base Case
84.86 USD
Overvaluation 47%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Insulet Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PODD stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Insulet Corp

Provide an overview of the primary business activities
of Insulet Corp.

What unique competitive advantages
does Insulet Corp hold over its rivals?

What risks and challenges
does Insulet Corp face in the near future?

Has there been any significant insider trading activity
in Insulet Corp recently?

Summarize the latest earnings call
of Insulet Corp.

What significant events have occurred
in Insulet Corp over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Insulet Corp.

Provide P/S
for Insulet Corp.

Provide P/E
for Insulet Corp.

Provide P/OCF
for Insulet Corp.

Provide P/FCFE
for Insulet Corp.

Provide P/B
for Insulet Corp.

Provide EV/S
for Insulet Corp.

Provide EV/GP
for Insulet Corp.

Provide EV/EBITDA
for Insulet Corp.

Provide EV/EBIT
for Insulet Corp.

Provide EV/OCF
for Insulet Corp.

Provide EV/FCFF
for Insulet Corp.

Provide EV/IC
for Insulet Corp.

Show me price targets
for Insulet Corp made by professional analysts.

What are the Revenue projections
for Insulet Corp?

How accurate were the past Revenue estimates
for Insulet Corp?

What are the Net Income projections
for Insulet Corp?

How accurate were the past Net Income estimates
for Insulet Corp?

What are the EPS projections
for Insulet Corp?

How accurate were the past EPS estimates
for Insulet Corp?

What are the EBIT projections
for Insulet Corp?

How accurate were the past EBIT estimates
for Insulet Corp?

Compare the revenue forecasts
for Insulet Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Insulet Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Insulet Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Insulet Corp compared to its peers.

Compare the P/E ratios
of Insulet Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Insulet Corp with its peers.

Analyze the financial leverage
of Insulet Corp compared to its main competitors.

Show all profitability ratios
for Insulet Corp.

Provide ROE
for Insulet Corp.

Provide ROA
for Insulet Corp.

Provide ROIC
for Insulet Corp.

Provide ROCE
for Insulet Corp.

Provide Gross Margin
for Insulet Corp.

Provide Operating Margin
for Insulet Corp.

Provide Net Margin
for Insulet Corp.

Provide FCF Margin
for Insulet Corp.

Show all solvency ratios
for Insulet Corp.

Provide D/E Ratio
for Insulet Corp.

Provide D/A Ratio
for Insulet Corp.

Provide Interest Coverage Ratio
for Insulet Corp.

Provide Altman Z-Score Ratio
for Insulet Corp.

Provide Quick Ratio
for Insulet Corp.

Provide Current Ratio
for Insulet Corp.

Provide Cash Ratio
for Insulet Corp.

What is the historical Revenue growth
over the last 5 years for Insulet Corp?

What is the historical Net Income growth
over the last 5 years for Insulet Corp?

What is the current Free Cash Flow
of Insulet Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Insulet Corp.

Financials

Balance Sheet Decomposition
Insulet Corp

Current Assets 1.6B
Cash & Short-Term Investments 650.7m
Receivables 359.7m
Other Current Assets 572.5m
Non-Current Assets 1B
PP&E 692.8m
Intangibles 150.4m
Other Non-Current Assets 162.1m
Current Liabilities 451.2m
Accounts Payable 19.2m
Accrued Liabilities 377.8m
Other Current Liabilities 54.2m
Non-Current Liabilities 1.4B
Long-Term Debt 1.4B
Other Non-Current Liabilities 37.9m
Efficiency

Earnings Waterfall
Insulet Corp

Revenue
1.7B USD
Cost of Revenue
-537.2m USD
Gross Profit
1.2B USD
Operating Expenses
-939.9m USD
Operating Income
220m USD
Other Expenses
-13.7m USD
Net Income
206.3m USD

Free Cash Flow Analysis
Insulet Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PODD Profitability Score
Profitability Due Diligence

Insulet Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Exceptional 3-Years Revenue Growth
Exceptional ROE
55/100
Profitability
Score

Insulet Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

PODD Solvency Score
Solvency Due Diligence

Insulet Corp's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
56/100
Solvency
Score

Insulet Corp's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PODD Price Targets Summary
Insulet Corp

Wall Street analysts forecast PODD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PODD is 241.57 USD with a low forecast of 210.08 USD and a high forecast of 283.5 USD.

Lowest
Price Target
210.08 USD
30% Upside
Average
Price Target
241.57 USD
50% Upside
Highest
Price Target
283.5 USD
76% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PODD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PODD Price
Insulet Corp

1M 1M
-2%
6M 6M
+16%
1Y 1Y
-50%
3Y 3Y
-46%
5Y 5Y
+94%
10Y 10Y
+302%
Annual Price Range
161.36
52w Low
127.77
52w High
330.23
Price Metrics
Average Annual Return 41.43%
Standard Deviation of Annual Returns 46.16%
Max Drawdown -61%
Shares Statistics
Market Capitalization 11.3B USD
Shares Outstanding 70 022 496
Percentage of Shares Shorted 5.26%

PODD Return Decomposition
Main factors of price return

What is price return decomposition?

PODD News

Other Videos

Last Important Events
Insulet Corp

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Insulet Corp

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Insulet Corp Logo
Insulet Corp

Country

United States of America

Industry

Health Care

Market Cap

11.3B USD

Dividend Yield

0%

Description

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 2,300 full-time employees. The company went IPO on 2007-05-15. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. The company can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.

Contact

MASSACHUSETTS
Acton
100 Nagog Park
+19786007000.0
https://www.omnipod.com

IPO

2007-05-15

Employees

2 300

Officers

President, CEO & Director
Dr. James R. Hollingshead Ph.D.
Director & Advisor
Ms. Shacey Petrovic
Executive VP, Chief Product & Customer Experience Officer
Mr. Eric Benjamin
Group VP, Chief Accounting Officer, Controller & Interim CFO and Treasurer
Ms. Lauren Budden
Senior Vice President of Global Operations
Mr. Prem Singh
Senior VP & CTO
Mr. Mark Field
Show More
Vice President of Investor Relations
Ms. Deborah R. Gordon CPA
Senior VP & General Counsel
Mr. John Wodick Kapples
Senior VP of Regulatory Affairs, Quality Assurance & Compliance
Ms. Laetitia Cousin
Senior Director of Corporate Communications
Angela Geryak Wiczek
Show Less

See Also

Discover More
What is the Intrinsic Value of one PODD stock?

The intrinsic value of one PODD stock under the Base Case scenario is 84.86 USD.

Is PODD stock undervalued or overvalued?

Compared to the current market price of 161.36 USD, Insulet Corp is Overvalued by 47%.